2784 Stock Overview
Through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Alfresa Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,154.50 |
| 52 Week High | JP¥2,554.50 |
| 52 Week Low | JP¥1,929.00 |
| Beta | 0.0027 |
| 1 Month Change | -4.65% |
| 3 Month Change | -4.35% |
| 1 Year Change | -10.49% |
| 3 Year Change | 39.90% |
| 5 Year Change | -5.38% |
| Change since IPO | 136.11% |
Recent News & Updates
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations
Nov 21
Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results
Nov 11Recent updates
Alfresa Holdings' (TSE:2784) Solid Earnings May Rest On Weak Foundations
Nov 21Here's What Analysts Are Forecasting For Alfresa Holdings Corporation (TSE:2784) After Its Half-Year Results
Nov 11Does Alfresa Holdings (TSE:2784) Deserve A Spot On Your Watchlist?
Oct 22The Returns On Capital At Alfresa Holdings (TSE:2784) Don't Inspire Confidence
Oct 08Investor Optimism Abounds Alfresa Holdings Corporation (TSE:2784) But Growth Is Lacking
Jul 30Alfresa Holdings (TSE:2784) Seems To Use Debt Rather Sparingly
Jul 12We Ran A Stock Scan For Earnings Growth And Alfresa Holdings (TSE:2784) Passed With Ease
Jun 25Alfresa Holdings (TSE:2784) Will Be Looking To Turn Around Its Returns
Jun 06Alfresa Holdings' (TSE:2784) Earnings Offer More Than Meets The Eye
May 22Is There An Opportunity With Alfresa Holdings Corporation's (TSE:2784) 32% Undervaluation?
Apr 19Alfresa Holdings' (TSE:2784) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 12Alfresa Holdings' (TSE:2784) Dividend Will Be Increased To ¥35.00
Feb 27Shareholder Returns
| 2784 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -2.8% | -2.0% | -1.5% |
| 1Y | -10.5% | -9.4% | 13.7% |
Return vs Industry: 2784 underperformed the JP Healthcare industry which returned -9.4% over the past year.
Return vs Market: 2784 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 2784 volatility | |
|---|---|
| 2784 Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 2784 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 2784's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 12,517 | Ryuji Arakawa | www.alfresa.com |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.
Alfresa Holdings Corporation Fundamentals Summary
| 2784 fundamental statistics | |
|---|---|
| Market cap | JP¥402.68b |
| Earnings (TTM) | JP¥31.77b |
| Revenue (TTM) | JP¥2.89t |
12.7x
P/E Ratio0.1x
P/S RatioIs 2784 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2784 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.89t |
| Cost of Revenue | JP¥2.68t |
| Gross Profit | JP¥209.46b |
| Other Expenses | JP¥177.68b |
| Earnings | JP¥31.77b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | 170.00 |
| Gross Margin | 7.26% |
| Net Profit Margin | 1.10% |
| Debt/Equity Ratio | 6.1% |
How did 2784 perform over the long term?
See historical performance and comparisonDividends
3.0%
Current Dividend Yield36%
Payout RatioDoes 2784 pay a reliable dividends?
See 2784 dividend history and benchmarks| Alfresa Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 04 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 164 days |
Does 2784 pay a reliable dividends?
See 2784 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:01 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alfresa Holdings Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Toshihide Yoda | Barclays |
| Ritsuo Watanabe | BofA Global Research |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |